Improving the cost-effectiveness of photographic screening for diabetic macular oedema: A prospective, multi-centre, UK study

British Journal of Ophthalmology

Volumn 98, Issue 8, 2014, Pages 1042-1049

  Prescott, Gordon ^a   Sharp, Peter ^a   Goatman, Keith ^a   Scotland, Graham ^a   Fleming, Alan ^a   Philip, Sam ^b   Staff, Roger ^c   Santiago, Cynthia ^b   Borooah, Shyamanga ^d   Broadbent, Deborah ^e,f   Chong, Victor ^g   Dodson, Paul ^h   Harding, Simon ^e,f   Leese, Graham ⁱ   Megaw, Roly ^d   Styles, Caroline ^j   Swa, Ken ^k   Wharton, Helen ^l   Olson, John ^m  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c NHS GRAMPIAN   (United Kingdom)

^d PRINCESS ALEXANDRA EYE PAVILION   (United Kingdom)

^e ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g OXFORD EYE HOSPITAL   (United Kingdom)

^h ASTON UNIVERSITY   (United Kingdom)

ⁱ NINEWELLS HOSPITAL   (United Kingdom)

^j QUEEN MARGARET HOSPITAL   (United Kingdom)

^k INFORMATION SERVICES DIVISION   (United Kingdom)

^l BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^m Retinal Screening   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOMATION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETIC MACULAR EDEMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL IMAGING; DISEASE CLASSIFICATION; EYE PHOTOGRAPHY; FEMALE; HEALTH CARE COST; HUMAN; INTRAOCULAR HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MICROANEURYSM; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM;

DIAGNOSTIC TESTS/INVESTIGATION; MACULA; RETINA;

ADULT; AGED; AUTOMATION; COST-BENEFIT ANALYSIS; DIABETIC RETINOPATHY; FEMALE; GREAT BRITAIN; HUMANS; MACULAR EDEMA; MALE; MASS SCREENING; MIDDLE AGED; PHOTOGRAPHY; PROSPECTIVE STUDIES; QUALITY IMPROVEMENT; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84905112725     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-304338     Document Type: Article

References (21)

1. HTA. Can automated diabetic retinopathy image assessment software replace one or more steps of manual imaging grading and is this cost-effective for the NHS Diabetic Eye Screening Programme? http://www.hta.ac.uk/2923 (accessed 21 Apr 2013).
2. Goatman KA. A reference standard for the measurement of macular oedema. Br J Ophthalmol 2006;90:1197-202. (Pubitemid 44351156)
3. Massin P, Girach A, Erginay A, et al. Optical coherence tomography: a key to the future management of patients with diabetic macular oedema. Acta Ophthalmol Scand 2006;84:466-74. (Pubitemid 44109046)
4. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(Suppl):766-85.
5. Goatman KA, Philip S, Fleming AD, et al. External quality assurance for image grading in the Scottish Diabetic Retinopathy Screening Programme. Diabet Med 2012;29:776-83.
6. Fleming AD, Goatman KA, Philip S, et al. on behalf of the Scottish Diabetic Retinopathy Clinical Research Network. The role of haemorrhage and exudate detection in automated grading of diabetic retinopathy. Br J Ophthalmol 2010;94:706-11.
7. Scotland GS, McNamee P, Fleming AD, et al. on behalf of the Scottish Diabetic Retinopathy Clinical Research Network. Costs and consequences of automated algorithms versus manual grading for the detection of referable diabetic retinopathy. Br J Ophthalmol 2010;94:712-19.
8. Kish L. Survey sampling. New York: Wiley, 1965:424-6.
9. Philip S, Fleming AD, Goatman KA, et al. The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol 2007;91:1512-17. (Pubitemid 350044057)
10. Bethlehem J. Weighting. In: Lavrakas PJ, ed. The encyclopedia of survey research methods. Vol. 2. New York: Sage, 2008:957-60.
11. Sapsford R. Survey research. London: Sage, 1999:31-2.
12. Warwick D, Lininger CA. The sample survey: theory and practice. New York: McGraw-Hill, 1975:273-4.
13. Altman DG, Machin D, Bryant TN, et al. Statistics with confidence. London: BMJ Books, 2000:46-8.
14. Early Treatment for Diabetic Retinopathy Study. Photocoagulation for Diabetic Macular Edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985;103:1796-806.
15. Jyothi S, Sivaprasad S. Five-year visual outcome following laser photocoagulation of diabetic macular oedema. Eye 2011;25:850-9.
16. Department of Health 2010; NHS reference costs 2009-2010. https://www.gov.uk/government/publications/nhs-reference-costs-2009-2010 (accessed 21 Apr 2013).
17. PSSRU. Unit costs of health and social care 2010 . Canterbury: Personal Social Services Research Unit, University of Kent, 2010.
18. Meads C, Hyde C. What is the cost of blindness? Br J Ophthalmol 2003;87:1201-4. (Pubitemid 37193905)
19. McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 2008;26:733-44.
20. Briggs A, Claxton C, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press, 2007:121-63.
21. National Institute for Health and Clinical Excellence. Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237) National Institute for Health and Clinical Excellence site. http://www.nice.org.uk/nicemedia/live/14082/62873/62873.pdf. (accessed 21 Apr. 2013)